This announcement is a separate document:
エーザイ：抗アミロイドβプロトフィブリル抗体「レケンビ」の売上収益（速報）について
Eisai: Regarding the sales revenue (preliminary report) of the anti-amyloid β protofibril antibody 'Leckenbi'.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.